Clover Health Investments, Corp.
$2.23
▲
1.18%
2026-04-21 06:05:00
www.cloverhealth.com
NMS: CLOV
Explore Clover Health Investments, Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.15 B
Current Price
$2.23
52W High / Low
$3.92 / $1.58
Stock P/E
—
Book Value
$0.59
Dividend Yield
—
ROCE
-25.75%
ROE
-26.33%
Face Value
—
EPS
$-0.17
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
724
Beta
2.25
Debt / Equity
—
Current Ratio
1.47
Quick Ratio
1.47
Forward P/E
21.44
Price / Sales
0.53
Enterprise Value
$892.35 M
EV / EBITDA
-10.46
EV / Revenue
0.46
Rating
None
Target Price
$2.82
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Progyny, Inc. | $18.64 | 24.25 | $1.42 B | — | 15.79% | 12.48% | $28.75 / $16.1 | $6.24 |
| 2. | Humana Inc. | $216 | 21.97 | $26.04 B | 1.68% | — | 7.04% | $315.35 / $163.11 | $146.42 |
| 3. | Oscar Health, Inc. | $16.44 | — | $4.9 B | — | — | -44.35% | $23.8 / $10.69 | $3.29 |
| 4. | UnitedHealth Group Incorporated | $354.97 | 26.8 | $323.02 B | 2.73% | 9.74% | 12.54% | $489.79 / $234.6 | $103.87 |
| 5. | Centene Corporation | $39.26 | — | $19.34 B | — | -0.78% | -28.68% | $64.15 / $25.08 | $40.58 |
| 6. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
| 7. | Alignment Healthcare, Inc. | $21.56 | — | $4.34 B | — | 2.9% | -0.7% | $23.87 / $11.62 | $0.88 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 487.71 M | 496.65 M | 477.62 M | 462.33 M | 336.96 M | — |
| Operating Profit | -49.32 M | -24.38 M | -10.56 M | -1.27 M | -21.45 M | — |
| Net Profit | -49.32 M | -24.38 M | -10.58 M | -1.27 M | -22.09 M | — |
| EPS in Rs | -0.11 | -0.06 | -0.02 | -0 | -0.05 | -0.02 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.92 B | 1.37 B | 1.26 B | 1.1 B |
| Operating Profit | -85.53 M | -45.46 M | -179.56 M | -286.66 M |
| Net Profit | -85.55 M | -43.01 M | -213.36 M | -339.57 M |
| EPS in Rs | -0.2 | -0.1 | -0.5 | -0.79 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 541.01 M | 580.74 M | 570.67 M | 808.62 M |
| Total Liabilities | 232.31 M | 239.6 M | 284.28 M | 451.73 M |
| Equity | 308.7 M | 341.14 M | 286.39 M | 356.89 M |
| Current Assets | 307.86 M | 343.12 M | 427.97 M | 625 M |
| Current Liabilities | 208.82 M | 213.52 M | 261.12 M | 431.51 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -66.93 M | 34.84 M | -144.66 M | -203.93 M |
| Investing CF | 4.08 M | 0.56 M | 140.01 M | 95.13 M |
| Financing CF | -53.38 M | -17.36 M | -5.07 M | -4.96 M |
| Free CF | -68.98 M | 33.29 M | -145.25 M | -208.39 M |
| Capex | -2.04 M | -1.56 M | -0.58 M | -4.47 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 8.77% | 14.96% | — | — |
| Earnings Growth % | 79.84% | 37.17% | — | — |
| Profit Margin % | -3.14% | -16.93% | -30.97% | — |
| Operating Margin % | -3.32% | -14.24% | -26.14% | — |
| Gross Margin % | 26.61% | 20.3% | 9.44% | — |
| EBITDA Margin % | -3.28% | -16.47% | -22.98% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.